Why patients don't take part in cancer clinical trials: an overview of the literature Clinical
trials have been recognized extensively within the literature as a crucial component in the …

AIM Our aim was to undertake a systematic review of the relevant literature relating to the
barriers, modifiers and benefits involved in participating in randomised controlled trials of …

OBJECTIVE: To investigate the barriers, modifiers, and benefits involved in participating in
randomized controlled trials of cancer therapies as perceived by health care providers and …

Despite widespread agreement about the value of clinical trials, the proportion of patients
who are enrolled in such trials is often considered to be too low. A comprehensive literature …

Background Research and cancer care are closely intertwined; however, it is not clear
whether physicians and nurses believe that clinical trials offer the best treatment for patients …

Background Clinical trials are the principal means by which new treatment approaches are
evaluated in medicine. It has been argued that randomised clinical trials provide the highest …

Although clinical trial research is required for the development of improved treatment
strategies, very few cancer patients participate in these studies. The purpose of this study …

Importance Many cancer clinical investigators view clinical trials as offering better care for
patients than routine clinical care. However, definitive evidence of clinical benefit from trial …

Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …

Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …